Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Vittecoq

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Clinical and Experimental Immunology|November 6, 2014
Usefulness of monitoring of B cell depletion in rituximab-treated rheumatoid arthritis patients in order to predict clinical relapse: a prospective observational studyA-P Trouvin, S Jacquot, S Grigioni, et al.
Joint Bone Spine|March 10, 2001
Prospective X-ray densitometry and ultrasonography study of the hand bones of patients with rheumatoid arthritis of recent onsetA Daragon, K Krzanowska, O Vittecoq, et al.
Arthritis Care & Research|December 4, 2012
Interstitial lung disease in anti-Jo-1 patients with antisynthetase syndromeI Marie, S Josse, P Y Hatron, et al.
BMC Cancer|January 8, 2020
Crizotinib-induced osteitis mimicking bone metastasis in a stage IV ALK-rearranged NSCLC patient: a case reportF Guisier, N Piton, M Bellefleur, et al.
Rheumatology (Oxford, England)|August 11, 2006
Autoantibodies, metalloproteinases and bone markers in rheumatoid arthritis patients are unable to predict their responses to infliximabT Lequerré, F Jouen, M Brazier, et al.
Arthritis and Rheumatism|January 22, 2000
Evolution of chronic recurrent multifocal osteitis toward spondylarthropathy over the long termO Vittecoq, L A Said, C Michot, et al.
Revue Du Rhumatisme (English Ed.)|May 1, 1996
A study of long-term survival, functional outcome and quality of life in patients with polymyositis or dermatomyositisB Drouet, X Le Loët, O Vittecoq, et al.
Journal of Clinical Immunology|July 1, 2008
Impact of three anti-TNFalpha biologics on existing and emergent autoimmunity in rheumatoid arthritis and spondylarthropathy patientsH Bacquet-Deschryver, F Jouen, M Quillard, et al.
Autoimmunity Reviews|February 2, 2016
Long term outcome of patients with low level of cryoglobulin (<0.05g/L)V Eble, B Legallicier, P Joly, et al.
Journal of Clinical Immunology|March 7, 2008
Anti-annexin II antibodies in systemic autoimmune diseases and antiphospholipid syndromeV Salle, J C Mazière, A Smail, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Clinical and Experimental Immunology|November 6, 2014
Usefulness of monitoring of B cell depletion in rituximab-treated rheumatoid arthritis patients in order to predict clinical relapse: a prospective observational studyA-P Trouvin, S Jacquot, S Grigioni, et al.
Joint Bone Spine|March 10, 2001
Prospective X-ray densitometry and ultrasonography study of the hand bones of patients with rheumatoid arthritis of recent onsetA Daragon, K Krzanowska, O Vittecoq, et al.
Arthritis Care & Research|December 4, 2012
Interstitial lung disease in anti-Jo-1 patients with antisynthetase syndromeI Marie, S Josse, P Y Hatron, et al.
BMC Cancer|January 8, 2020
Crizotinib-induced osteitis mimicking bone metastasis in a stage IV ALK-rearranged NSCLC patient: a case reportF Guisier, N Piton, M Bellefleur, et al.
Rheumatology (Oxford, England)|August 11, 2006
Autoantibodies, metalloproteinases and bone markers in rheumatoid arthritis patients are unable to predict their responses to infliximabT Lequerré, F Jouen, M Brazier, et al.
Arthritis and Rheumatism|January 22, 2000
Evolution of chronic recurrent multifocal osteitis toward spondylarthropathy over the long termO Vittecoq, L A Said, C Michot, et al.
Revue Du Rhumatisme (English Ed.)|May 1, 1996
A study of long-term survival, functional outcome and quality of life in patients with polymyositis or dermatomyositisB Drouet, X Le Loët, O Vittecoq, et al.
Journal of Clinical Immunology|July 1, 2008
Impact of three anti-TNFalpha biologics on existing and emergent autoimmunity in rheumatoid arthritis and spondylarthropathy patientsH Bacquet-Deschryver, F Jouen, M Quillard, et al.
Autoimmunity Reviews|February 2, 2016
Long term outcome of patients with low level of cryoglobulin (<0.05g/L)V Eble, B Legallicier, P Joly, et al.
Journal of Clinical Immunology|March 7, 2008
Anti-annexin II antibodies in systemic autoimmune diseases and antiphospholipid syndromeV Salle, J C Mazière, A Smail, et al.
Pageof 6